Merck KGaA’s MilliporeSigma subsidiary will help Saudi Arabia-based SaudiVax design and launch a new biologics and vaccine manufacturing facility serving the Middle East and North Africa, MilliporeSigma announced Wednesday.
The collaboration aims to “localize” the production of “high-quality, Halal, and affordable vaccines and biotherapeutics” in Saudi Arabia, according to MilliporeSigma’s press release.